WebAug 19, 2024 · August 19, 2024 by Talent4Boards Team. – USA, CA – BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target the molecular causes of aging to extend healthy human lifespan, today announced the appointment of Rekha Hemrajani and Dr. Jason Coloma to its board of directors. WebMay 16, 2024 · About BioAge Labs, Inc. BioAge is a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging.
BioAge Labs to Present Data on Novel Brain-Penetrant NLRP3 …
WebSep 14, 2024 · Bioage Labs now intends to set up an internal laboratory to experiment with different compounds, while building out its team. ... BioAge's management team consists of Chris Morrissey, its head of bioinformatics, and Jonah Sinick, head of data science. In total, the company employs eight people, but that is set to expand given the new financing ... WebBioAge Labs Profile and History. BioAge is a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular … mapleshade assisted living plano tx
BioAge Labs to Participate in Truist Symposium on AI-driven Drug ...
WebApr 30, 2024 · add_box. RICHMOND, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc., a biotechnology company developing medicines to treat aging and age-related diseases, today announced that it has ... WebJun 20, 2016 · Inflammation mediated by the NLRP3 inflammasome drives multiple age-related illnesses. BioAge is developing novel, CNS-penetrant NLRP3 inhibitors to…. Liked by Naisha S. At the World Muscle ... WebSome drug abuse treatments are a month long, but many can last weeks longer. Some drug abuse rehabs can last six months or longer. At Your First Step, we can help you to find 1 … kreller brand protection